This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and anti-viral efficacy of the PGDM1400 and PGT121 mAbs for HIV prevention and therapy.
Contact research investigator to learn more about this study by filling out the form
By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.
Call 1-800-667-5356, Monday-Friday, 8:30am-5:00pm or
For help with specialty consultations, call 617-667-2020, Monday-Friday, 8:30am-5:00pm
or refer to our ED
Schedule an appointment through
Walk-ins are welcome or appointments can be booked online. If this is an emergency, call 911 or visit the nearest emergency room.